However, as noted earlier, inhibition of GCN2 sensitizes both ALL and AML cell lines to treatment with L-asparaginase [32], thus, indicating the complexity of the anti-leukemic roles of GCN2. The gene discussed is EIF2AK4; the disease is acute myeloid leukemia.